Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
Abstract Background Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cyt...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-023-03233-0 |
_version_ | 1827781174453338112 |
---|---|
author | Young Song Myung Il Bae Dong Woo Han Eun Jung Park Sujung Park Sung Yeon Ham |
author_facet | Young Song Myung Il Bae Dong Woo Han Eun Jung Park Sujung Park Sung Yeon Ham |
author_sort | Young Song |
collection | DOAJ |
description | Abstract Background Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods We retrospectively analyzed the data of 99 patients with preoperative BIA data among those who underwent CRS and HIPEC. The association between BIA-derived parameters and intraoperative peritoneal cancer index (PCI) score was assessed. Predictive analysis for the occurrence of postoperative morbidities including major complications (Clavien–Dindo classification 3–4) and re-admission within 30 days after surgery as well as 1 year mortality was also performed. Results BIA-derived mineral (r = 0.224, p = 0.027), fat (r = − 0.202, p = 0.048), and total body water (TBW)/fat-free mass (FFM) (r = − 0.280, p = 0.005) showed significant associations with intraoperative PCI score. Lower TBW/FFM was an independent predictor of major postoperative complications (OR 0.047, 95% CI 0.003–0.749, p = 0.031) and re-admission (OR 0.094, 95% CI 0.014–0.657, p = 0.017) within 30 days after surgery. Higher fat mass was also independently associated with a higher risk of major postoperative complications (OR 1.120, 95% CI 1.006–1.248, p = 0.039) and re-admission (OR 1.123, 95% CI 1.024–1.230, p = 0.013). Intraoperative PCI score > 20 (OR 4.489, 95% CI 1.191–16.917, p = 0.027) and re-admission within 30 days after surgery (OR 5.269, 95% CI 1.288–21.547, p = 0.021) independently predicted postoperative 1-year mortality. Conclusions We demonstrate that preoperative BIA-derived TBW/FFM and fat mass were significantly correlated with metastatic extent, assessed by PCI score, in patients with peritoneal carcinomatosis. In addition, BIA-derived TBW/FFM and fat mass showed independent predictability for postoperative 30-day major complications and re-admission in patients undergoing CRS and HIPEC. Our findings suggest that assessment of BIA may improve discrete risk stratification in patients who are planned to receive CRS and HIPEC. |
first_indexed | 2024-03-11T15:15:09Z |
format | Article |
id | doaj.art-cb7ccc63535e495aa4c5d72c9c760c43 |
institution | Directory Open Access Journal |
issn | 1477-7819 |
language | English |
last_indexed | 2024-03-11T15:15:09Z |
publishDate | 2023-10-01 |
publisher | BMC |
record_format | Article |
series | World Journal of Surgical Oncology |
spelling | doaj.art-cb7ccc63535e495aa4c5d72c9c760c432023-10-29T12:26:10ZengBMCWorld Journal of Surgical Oncology1477-78192023-10-012111910.1186/s12957-023-03233-0Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapyYoung Song0Myung Il Bae1Dong Woo Han2Eun Jung Park3Sujung Park4Sung Yeon Ham5Department of Anesthesiology and Pain Medicine, Yonsei University College of MedicineDepartment of Anesthesiology and Pain Medicine, Yonsei University College of MedicineDepartment of Anesthesiology and Pain Medicine, Yonsei University College of MedicineDivision of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of MedicineDepartment of Anesthesiology and Pain Medicine, Yonsei University College of MedicineDepartment of Anesthesiology and Pain Medicine, Yonsei University College of MedicineAbstract Background Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods We retrospectively analyzed the data of 99 patients with preoperative BIA data among those who underwent CRS and HIPEC. The association between BIA-derived parameters and intraoperative peritoneal cancer index (PCI) score was assessed. Predictive analysis for the occurrence of postoperative morbidities including major complications (Clavien–Dindo classification 3–4) and re-admission within 30 days after surgery as well as 1 year mortality was also performed. Results BIA-derived mineral (r = 0.224, p = 0.027), fat (r = − 0.202, p = 0.048), and total body water (TBW)/fat-free mass (FFM) (r = − 0.280, p = 0.005) showed significant associations with intraoperative PCI score. Lower TBW/FFM was an independent predictor of major postoperative complications (OR 0.047, 95% CI 0.003–0.749, p = 0.031) and re-admission (OR 0.094, 95% CI 0.014–0.657, p = 0.017) within 30 days after surgery. Higher fat mass was also independently associated with a higher risk of major postoperative complications (OR 1.120, 95% CI 1.006–1.248, p = 0.039) and re-admission (OR 1.123, 95% CI 1.024–1.230, p = 0.013). Intraoperative PCI score > 20 (OR 4.489, 95% CI 1.191–16.917, p = 0.027) and re-admission within 30 days after surgery (OR 5.269, 95% CI 1.288–21.547, p = 0.021) independently predicted postoperative 1-year mortality. Conclusions We demonstrate that preoperative BIA-derived TBW/FFM and fat mass were significantly correlated with metastatic extent, assessed by PCI score, in patients with peritoneal carcinomatosis. In addition, BIA-derived TBW/FFM and fat mass showed independent predictability for postoperative 30-day major complications and re-admission in patients undergoing CRS and HIPEC. Our findings suggest that assessment of BIA may improve discrete risk stratification in patients who are planned to receive CRS and HIPEC.https://doi.org/10.1186/s12957-023-03233-0Bioelectrical impedance analysisHyperthermic intraperitoneal chemotherapyPrognosis |
spellingShingle | Young Song Myung Il Bae Dong Woo Han Eun Jung Park Sujung Park Sung Yeon Ham Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy World Journal of Surgical Oncology Bioelectrical impedance analysis Hyperthermic intraperitoneal chemotherapy Prognosis |
title | Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
title_full | Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
title_fullStr | Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
title_full_unstemmed | Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
title_short | Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
title_sort | prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy |
topic | Bioelectrical impedance analysis Hyperthermic intraperitoneal chemotherapy Prognosis |
url | https://doi.org/10.1186/s12957-023-03233-0 |
work_keys_str_mv | AT youngsong prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy AT myungilbae prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy AT dongwoohan prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy AT eunjungpark prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy AT sujungpark prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy AT sungyeonham prognosticroleofbodycompositioninperitonealcarcinomatosispatientsundergoingcytoreductionandhyperthermicintraperitonealchemotherapy |